カテゴリー： QYResearch, 世界

世界のテストステロン市場

【英語タイトル】Global Testosterone (CAS 58-22-0) Sales Market Report 2022

QYResearchが出版した調査資料（RG-001003）・商品コード：RG-001003
・発行会社（調査会社）：QYResearch
・発行日：2022年6月
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,000 ⇒換算￥584,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD6,000 ⇒換算￥876,000見積依頼/購入/質問フォーム
Enterprise License（法人閲覧用）USD8,000 ⇒換算￥1,168,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Due to the COVID-19 pandemic, the global Testosterone (CAS 58-22-0) market size was US$ xx million in 2021 and is forecast to a readjusted size of US$ xx million by 2028 with a CAGR of xx% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Powder accounting for xx% of the Testosterone (CAS 58-22-0) global market in 2021, is projected to value US$ xx million by 2028, growing at a revised xx% CAGR from 2022 to 2028. While Capsule segment is altered to an xx % CAGR throughout this forecast period.
The United States Testosterone (CAS 58-22-0) market size was US$ xx million in 2021, while China was US$ xx million. The proportion of the United States was xx% in 2021, while Chinese percentage was xx%, and it is predicted that China share will reach xx% in 2028, trailing a CAGR of xx % through the analysis period.
The global key manufacturers of Testosterone (CAS 58-22-0) include Pfizer CentreOne, Sun Pharmaceutical, Symbiotec Pharmalab, Avik Pharmaceutical, Zhejiang Xianju Pharmaceutical, Junye Pharmaceutical, Hubei Gedian Humanwell Pharmaceutical, and etc. In 2021, the global top five players occupied for a share approximately XX% in terms of revenue.
In United States, in terms of sales volume, in 2021, the top three players hold a share about XX%, while in China, top three players hold a share nearly XX%.
The global Testosterone (CAS 58-22-0) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Testosterone (CAS 58-22-0) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type
 Powder
 Micronized

Segment by Application
 Capsule
 Tablet
 Injection
 Gel

By Region
 United States
 Europe
 China
 Japan
 Southeast Asia
 India
 Other Regions

By Company
 Pfizer CentreOne
 Sun Pharmaceutical
 Symbiotec Pharmalab
 Avik Pharmaceutical
 Zhejiang Xianju Pharmaceutical
 Junye Pharmaceutical
 Hubei Gedian Humanwell Pharmaceutical

❖ レポートの目次 ❖

1 TESTOSTERONE (CAS 58-22-0) MARKET OVERVIEW
1.1 TESTOSTERONE (CAS 58-22-0) PRODUCT SCOPE
1.2 TESTOSTERONE (CAS 58-22-0) SEGMENT BY TYPE
1.2.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES BY TYPE (2017 & 2021 & 2028)
1.2.2 POWDER
1.2.3 MICRONIZED
1.3 TESTOSTERONE (CAS 58-22-0) SEGMENT BY APPLICATION
1.3.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES COMPARISON BY APPLICATION (2017 & 2021 & 2028)
1.3.2 CAPSULE
1.3.3 TABLET
1.3.4 INJECTION
1.3.5 GEL
1.4 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET ESTIMATES AND FORECASTS (2017-2028)
1.4.1 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET SIZE IN VALUE GROWTH RATE (2017-2028)
1.4.2 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET SIZE IN VOLUME GROWTH RATE (2017-2028)
1.4.3 GLOBAL TESTOSTERONE (CAS 58-22-0) PRICE TRENDS (2017-2028)
2 TESTOSTERONE (CAS 58-22-0) ESTIMATES AND FORECASTS BY REGION
2.1 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
2.2 GLOBAL TESTOSTERONE (CAS 58-22-0) RETROSPECTIVE MARKET SCENARIO BY REGION (2017-2022)
2.2.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES MARKET SHARE BY REGION (2017-2022)
2.2.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE MARKET SHARE BY REGION (2017-2022)
2.3 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET ESTIMATES AND FORECASTS BY REGION (2023-2028)
2.3.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES ESTIMATES AND FORECASTS BY REGION (2023-2028)
2.3.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE FORECAST BY REGION (2023-2028)
2.4 GEOGRAPHIC MARKET ANALYSIS: MARKET FACTS & FIGURES
2.4.1 UNITED STATES TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
2.4.2 EUROPE TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
2.4.3 CHINA TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
2.4.4 JAPAN TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
2.4.5 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
2.4.6 INDIA TESTOSTERONE (CAS 58-22-0) ESTIMATES AND PROJECTIONS (2017-2028)
3 TESTOSTERONE (CAS 58-22-0) COMPETITION LANDSCAPE BY PLAYERS
3.1 GLOBAL TOP TESTOSTERONE (CAS 58-22-0) PLAYERS BY SALES (2017-2022)
3.2 GLOBAL TOP TESTOSTERONE (CAS 58-22-0) PLAYERS BY REVENUE (2017-2022)
3.3 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN TESTOSTERONE (CAS 58-22-0) AS OF 2021)
3.4 GLOBAL TESTOSTERONE (CAS 58-22-0) AVERAGE PRICE BY COMPANY (2017-2022)
3.5 MANUFACTURERS TESTOSTERONE (CAS 58-22-0) MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE
3.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS
4 TESTOSTERONE (CAS 58-22-0) MARKET SIZE BY TYPE
4.1 GLOBAL TESTOSTERONE (CAS 58-22-0) HISTORIC MARKET REVIEW BY TYPE (2017-2022)
4.1.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES BY TYPE (2017-2022)
4.1.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE BY TYPE (2017-2022)
4.1.3 GLOBAL TESTOSTERONE (CAS 58-22-0) PRICE BY TYPE (2017-2022)
4.2 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET ESTIMATES AND FORECASTS BY TYPE (2023-2028)
4.2.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES FORECAST BY TYPE (2023-2028)
4.2.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE FORECAST BY TYPE (2023-2028)
4.2.3 GLOBAL TESTOSTERONE (CAS 58-22-0) PRICE FORECAST BY TYPE (2023-2028)
5 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET SIZE BY APPLICATION
5.1 GLOBAL TESTOSTERONE (CAS 58-22-0) HISTORIC MARKET REVIEW BY APPLICATION (2017-2022)
5.1.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES BY APPLICATION (2017-2022)
5.1.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE BY APPLICATION (2017-2022)
5.1.3 GLOBAL TESTOSTERONE (CAS 58-22-0) PRICE BY APPLICATION (2017-2022)
5.2 GLOBAL TESTOSTERONE (CAS 58-22-0) MARKET ESTIMATES AND FORECASTS BY APPLICATION (2023-2028)
5.2.1 GLOBAL TESTOSTERONE (CAS 58-22-0) SALES FORECAST BY APPLICATION (2023-2028)
5.2.2 GLOBAL TESTOSTERONE (CAS 58-22-0) REVENUE FORECAST BY APPLICATION (2023-2028)
5.2.3 GLOBAL TESTOSTERONE (CAS 58-22-0) PRICE FORECAST BY APPLICATION (2023-2028)
6 UNITED STATES TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
6.1 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
6.1.1 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
6.1.2 UNITED STATES TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
6.2 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
6.2.1 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
6.2.2 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
6.3 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
6.3.1 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
6.3.2 UNITED STATES TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
7 EUROPE TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
7.1 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
7.1.1 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
7.1.2 EUROPE TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
7.2 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
7.2.1 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
7.2.2 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
7.3 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
7.3.1 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
7.3.2 EUROPE TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
8 CHINA TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
8.1 CHINA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
8.1.1 CHINA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
8.1.2 CHINA TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
8.2 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
8.2.1 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
8.2.2 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
8.3 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
8.3.1 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
8.3.2 CHINA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
9 JAPAN TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
9.1 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
9.1.1 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
9.1.2 JAPAN TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
9.2 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
9.2.1 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
9.2.2 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
9.3 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
9.3.1 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
9.3.2 JAPAN TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
10 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
10.1 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
10.1.1 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
10.1.2 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
10.2 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
10.2.1 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
10.2.2 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
10.3 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
10.3.1 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
10.3.2 SOUTHEAST ASIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
11 INDIA TESTOSTERONE (CAS 58-22-0) MARKET FACTS & FIGURES
11.1 INDIA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY
11.1.1 INDIA TESTOSTERONE (CAS 58-22-0) SALES BY COMPANY (2017-2022)
11.1.2 INDIA TESTOSTERONE (CAS 58-22-0) REVENUE BY COMPANY (2017-2022)
11.2 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE
11.2.1 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2017-2022)
11.2.2 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY TYPE (2023-2028)
11.3 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION
11.3.1 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2017-2022)
11.3.2 INDIA TESTOSTERONE (CAS 58-22-0) SALES BREAKDOWN BY APPLICATION (2023-2028)
12 COMPANY PROFILES AND KEY FIGURES IN TESTOSTERONE (CAS 58-22-0) BUSINESS
12.1 PFIZER CENTREONE
12.1.1 PFIZER CENTREONE CORPORATION INFORMATION
12.1.2 PFIZER CENTREONE BUSINESS OVERVIEW
12.1.3 PFIZER CENTREONE TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.1.4 PFIZER CENTREONE TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.1.5 PFIZER CENTREONE RECENT DEVELOPMENT
12.2 SUN PHARMACEUTICAL
12.2.1 SUN PHARMACEUTICAL CORPORATION INFORMATION
12.2.2 SUN PHARMACEUTICAL BUSINESS OVERVIEW
12.2.3 SUN PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.2.4 SUN PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.2.5 SUN PHARMACEUTICAL RECENT DEVELOPMENT
12.3 SYMBIOTEC PHARMALAB
12.3.1 SYMBIOTEC PHARMALAB CORPORATION INFORMATION
12.3.2 SYMBIOTEC PHARMALAB BUSINESS OVERVIEW
12.3.3 SYMBIOTEC PHARMALAB TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.3.4 SYMBIOTEC PHARMALAB TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.3.5 SYMBIOTEC PHARMALAB RECENT DEVELOPMENT
12.4 AVIK PHARMACEUTICAL
12.4.1 AVIK PHARMACEUTICAL CORPORATION INFORMATION
12.4.2 AVIK PHARMACEUTICAL BUSINESS OVERVIEW
12.4.3 AVIK PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.4.4 AVIK PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.4.5 AVIK PHARMACEUTICAL RECENT DEVELOPMENT
12.5 ZHEJIANG XIANJU PHARMACEUTICAL
12.5.1 ZHEJIANG XIANJU PHARMACEUTICAL CORPORATION INFORMATION
12.5.2 ZHEJIANG XIANJU PHARMACEUTICAL BUSINESS OVERVIEW
12.5.3 ZHEJIANG XIANJU PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.5.4 ZHEJIANG XIANJU PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.5.5 ZHEJIANG XIANJU PHARMACEUTICAL RECENT DEVELOPMENT
12.6 JUNYE PHARMACEUTICAL
12.6.1 JUNYE PHARMACEUTICAL CORPORATION INFORMATION
12.6.2 JUNYE PHARMACEUTICAL BUSINESS OVERVIEW
12.6.3 JUNYE PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.6.4 JUNYE PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.6.5 JUNYE PHARMACEUTICAL RECENT DEVELOPMENT
12.7 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL
12.7.1 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CORPORATION INFORMATION
12.7.2 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL BUSINESS OVERVIEW
12.7.3 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) SALES, REVENUE AND GROSS MARGIN (2017-2022)
12.7.4 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL TESTOSTERONE (CAS 58-22-0) PRODUCTS OFFERED
12.7.5 HUBEI GEDIAN HUMANWELL PHARMACEUTICAL RECENT DEVELOPMENT
13 TESTOSTERONE (CAS 58-22-0) MANUFACTURING COST ANALYSIS
13.1 TESTOSTERONE (CAS 58-22-0) KEY RAW MATERIALS ANALYSIS
13.1.1 KEY RAW MATERIALS
13.1.2 KEY RAW MATERIALS PRICE TREND
13.1.3 KEY SUPPLIERS OF RAW MATERIALS
13.2 PROPORTION OF MANUFACTURING COST STRUCTURE
13.3 MANUFACTURING PROCESS ANALYSIS OF TESTOSTERONE (CAS 58-22-0)
13.4 TESTOSTERONE (CAS 58-22-0) INDUSTRIAL CHAIN ANALYSIS
14 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
14.1 MARKETING CHANNEL
14.2 TESTOSTERONE (CAS 58-22-0) DISTRIBUTORS LIST
14.3 TESTOSTERONE (CAS 58-22-0) CUSTOMERS
15 TESTOSTERONE (CAS 58-22-0) MARKET DYNAMICS
15.1 TESTOSTERONE (CAS 58-22-0) INDUSTRY TRENDS
15.2 TESTOSTERONE (CAS 58-22-0) MARKET DRIVERS
15.3 TESTOSTERONE (CAS 58-22-0) MARKET CHALLENGES
15.4 TESTOSTERONE (CAS 58-22-0) MARKET RESTRAINTS
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
17.1 RESEARCH METHODOLOGY
17.1.1 METHODOLOGY/RESEARCH APPROACH
17.1.2 DATA SOURCE
17.2 AUTHOR DETAILS
17.3 DISCLAIMER

LIST OF TABLES
Table 1. Global Testosterone (CAS 58-22-0) Sales (US$ Million) Growth Rate by Type (2017 & 2021 & 2028)
Table 2. Global Testosterone (CAS 58-22-0) Sales (US$ Million) Comparison by Application (2017 & 2021 & 2028)
Table 3. Global Market Testosterone (CAS 58-22-0) Market Size (US$ Million) by Region:2017 VS 2021 VS 2028
Table 4. Global Testosterone (CAS 58-22-0) Sales (Tons) by Region (2017-2022)
Table 5. Global Testosterone (CAS 58-22-0) Sales Market Share by Region (2017-2022)
Table 6. Global Testosterone (CAS 58-22-0) Revenue (US$ Million) Market Share by Region (2017-2022)
Table 7. Global Testosterone (CAS 58-22-0) Revenue Share by Region (2017-2022)
Table 8. Global Testosterone (CAS 58-22-0) Sales (Tons) Forecast by Region (2023-2028)
Table 9. Global Testosterone (CAS 58-22-0) Sales Market Share Forecast by Region (2023-2028)
Table 10. Global Testosterone (CAS 58-22-0) Revenue (US$ Million) Forecast by Region (2023-2028)
Table 11. Global Testosterone (CAS 58-22-0) Revenue Share Forecast by Region (2023-2028)
Table 12. Global Testosterone (CAS 58-22-0) Sales by Company (Tons) & (2017-2022)
Table 13. Global Testosterone (CAS 58-22-0) Sales Share by Company (2017-2022)
Table 14. Global Testosterone (CAS 58-22-0) Revenue by Company (US$ Million) & (2017-2022)
Table 15. Global Testosterone (CAS 58-22-0) Revenue Share by Company (2017-2022)
Table 16. Global Testosterone (CAS 58-22-0) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone (CAS 58-22-0) as of 2021)
Table 17. Global Market Testosterone (CAS 58-22-0) Average Price by Company (US$/Ton) & (2017-2022)
Table 18. Manufacturers Testosterone (CAS 58-22-0) Manufacturing Sites and Area Served
Table 19. Manufacturers Testosterone (CAS 58-22-0) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Testosterone (CAS 58-22-0) Sales by Type (Tons) & (2017-2022)
Table 22. Global Testosterone (CAS 58-22-0) Sales Share by Type (2017-2022)
Table 23. Global Testosterone (CAS 58-22-0) Revenue by Type (US$ Million) & (2017-2022)
Table 24. Global Testosterone (CAS 58-22-0) Price by Type (US$/Ton) & (2017-2022)
Table 25. Global Testosterone (CAS 58-22-0) Sales by Type (Tons) & (2023-2028)
Table 26. Global Testosterone (CAS 58-22-0) Revenue by Type (US$ Million) & (2023-2028)
Table 27. Global Testosterone (CAS 58-22-0) Price by Type (US$/Ton) & (2023-2028)
Table 28. Global Testosterone (CAS 58-22-0) Sales by Application (Tons) & (2017-2022)
Table 29. Global Testosterone (CAS 58-22-0) Sales Share by Application (2017-2022)
Table 30. Global Testosterone (CAS 58-22-0) Revenue by Application (US$ Million) & (2017-2022)
Table 31. Global Testosterone (CAS 58-22-0) Price by Application (US$/Ton) & (2017-2022)
Table 32. Global Testosterone (CAS 58-22-0) Sales by Application (Tons) & (2023-2028)
Table 33. Global Testosterone (CAS 58-22-0) Revenue Market Share by Application (US$ Million) & (2023-2028)
Table 34. Global Testosterone (CAS 58-22-0) Price by Application (US$/Ton) & (2023-2028)
Table 35. United States Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 36. United States Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 37. United States Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 38. United States Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 39. United States Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 40. United States Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 41. United States Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 42. United States Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 43. United States Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 44. United States Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 45. United States Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 46. United States Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 47. Europe Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 48. Europe Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 49. Europe Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 50. Europe Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 51. Europe Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 52. Europe Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 53. Europe Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 54. Europe Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 55. Europe Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 56. Europe Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 57. Europe Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 58. Europe Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 59. China Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 60. China Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 61. China Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 62. China Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 63. China Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 64. China Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 65. China Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 66. China Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 67. China Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 68. China Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 69. China Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 70. China Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 71. Japan Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 72. Japan Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 73. Japan Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 74. Japan Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 75. Japan Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 76. Japan Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 77. Japan Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 78. Japan Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 79. Japan Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 80. Japan Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 81. Japan Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 82. Japan Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 83. Southeast Asia Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 84. Southeast Asia Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 85. Southeast Asia Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 86. Southeast Asia Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 87. Southeast Asia Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 88. Southeast Asia Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 89. Southeast Asia Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 90. Southeast Asia Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 91. Southeast Asia Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 92. Southeast Asia Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 93. Southeast Asia Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 94. Southeast Asia Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 95. India Testosterone (CAS 58-22-0) Sales by Company (2017-2022) & (Tons)
Table 96. India Testosterone (CAS 58-22-0) Sales Market Share by Company (2017-2022)
Table 97. India Testosterone (CAS 58-22-0) Revenue by Company (2017-2022) & (US$ Million)
Table 98. India Testosterone (CAS 58-22-0) Revenue Market Share by Company (2017-2022)
Table 99. India Testosterone (CAS 58-22-0) Sales by Type (2017-2022) & (Tons)
Table 100. India Testosterone (CAS 58-22-0) Sales Market Share by Type (2017-2022)
Table 101. India Testosterone (CAS 58-22-0) Sales by Type (2023-2028) & (Tons)
Table 102. India Testosterone (CAS 58-22-0) Sales Market Share by Type (2023-2028)
Table 103. India Testosterone (CAS 58-22-0) Sales by Application (2017-2022) & (Tons)
Table 104. India Testosterone (CAS 58-22-0) Sales Market Share by Application (2017-2022)
Table 105. India Testosterone (CAS 58-22-0) Sales by Application (2023-2028) & (Tons)
Table 106. India Testosterone (CAS 58-22-0) Sales Market Share by Application (2023-2028)
Table 107. Pfizer CentreOne Corporation Information
Table 108. Pfizer CentreOne Description and Business Overview
Table 109. Pfizer CentreOne Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 110. Pfizer CentreOne Testosterone (CAS 58-22-0) Product
Table 111. Pfizer CentreOne Recent Development
Table 112. Sun Pharmaceutical Corporation Information
Table 113. Sun Pharmaceutical Description and Business Overview
Table 114. Sun Pharmaceutical Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Sun Pharmaceutical Testosterone (CAS 58-22-0) Product
Table 116. Sun Pharmaceutical Recent Development
Table 117. Symbiotec Pharmalab Corporation Information
Table 118. Symbiotec Pharmalab Description and Business Overview
Table 119. Symbiotec Pharmalab Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Symbiotec Pharmalab Testosterone (CAS 58-22-0) Product
Table 121. Symbiotec Pharmalab Recent Development
Table 122. Avik Pharmaceutical Corporation Information
Table 123. Avik Pharmaceutical Description and Business Overview
Table 124. Avik Pharmaceutical Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Avik Pharmaceutical Testosterone (CAS 58-22-0) Product
Table 126. Avik Pharmaceutical Recent Development
Table 127. Zhejiang Xianju Pharmaceutical Corporation Information
Table 128. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 129. Zhejiang Xianju Pharmaceutical Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Zhejiang Xianju Pharmaceutical Testosterone (CAS 58-22-0) Product
Table 131. Zhejiang Xianju Pharmaceutical Recent Development
Table 132. Junye Pharmaceutical Corporation Information
Table 133. Junye Pharmaceutical Description and Business Overview
Table 134. Junye Pharmaceutical Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Junye Pharmaceutical Testosterone (CAS 58-22-0) Product
Table 136. Junye Pharmaceutical Recent Development
Table 137. Hubei Gedian Humanwell Pharmaceutical Corporation Information
Table 138. Hubei Gedian Humanwell Pharmaceutical Description and Business Overview
Table 139. Hubei Gedian Humanwell Pharmaceutical Testosterone (CAS 58-22-0) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Hubei Gedian Humanwell Pharmaceutical Testosterone (CAS 58-22-0) Product
Table 141. Hubei Gedian Humanwell Pharmaceutical Recent Development
Table 142. Production Base and Market Concentration Rate of Raw Material
Table 143. Key Suppliers of Raw Materials
Table 144. Testosterone (CAS 58-22-0) Distributors List
Table 145. Testosterone (CAS 58-22-0) Customers List
Table 146. Testosterone (CAS 58-22-0) Market Trends
Table 147. Testosterone (CAS 58-22-0) Market Drivers
Table 148. Testosterone (CAS 58-22-0) Market Challenges
Table 149. Testosterone (CAS 58-22-0) Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources



★調査レポート[世界のテストステロン市場] (コード：RG-001003)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のテストステロン市場]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のコリン塩基市場
  • 5,6-ジヒドロキシインドールの世界市場
  • 世界の真空成形板市場
  • 世界のトリメチロールプロパントリアクリレート市場
  • 硫酸パラジウムの世界市場
  • イブプロフェンの世界市場
  • Global Asiatic acid (CAS 464-92-6) Market Research Report 2022
  • 世界の感圧紙市場
  • インデックスマッチングフィルム(IMフィルム)の世界市場
  • 世界のNMP（N-メチル-2-ピロリドン）市場 2022年

    • ◆H&Iグローバルリサーチのお客様（例）◆